Director, US HCP Marketing, Rheumatology, Sjögren's Disease

Join us as we transform immunology and deliver medicines that help autoimmune patients get their lives back. argenx is preparing for multi-dimensional expansion to reach more patients through a rich pipeline of differentiated assets, led by VYVGART, our first-in-class neonatal Fc receptor blocker approved for the treatment of gMG, and with the potential to treat patients across dozens of severe autoimmune diseases.

We are building a new kind of biotech company, one that maintains its roots as a science-based start-up and pushes our commitment to innovate across all corners of our business. We strive to inspire and grow our company, our partnerships, our science, and our people, because when we do, we deliver more for patients. argenx is a global immunology company developing therapies for individuals living with autoimmune diseases.

argenx is building a world-class portfolio of biologics in both early and late stages of development. VYVGART® / VYVGART Hytrulo® (efgartigimod) is approved for generalized Myasthenia Gravis (gMG) and Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) and is being evaluated for several additional indications, including three rheumatology indications: autoimmune myositis, Sjögren's disease, and systemic sclerosis. The Director, US HCP Marketing will lead the development and execution of the US HCP marketing strategy for Sjögren's disease, with near-term ownership of market development and disease state education to increase understanding of the disease, its burden, and unmet need among priority HCP audiences.

This role will shape the commercial strategy and build the foundation required for launch readiness. This role will report to the Senior Director of US HCP Marketing, Rheumatology Lead, and will serve as the HCP marketing lead for Sjögren's disease. The Director will partner closely with internal cross-functional leaders and external agencies to define and deliver integrated personal and non-personal engagement across field, digital, media, peer-to-peer, and national and regional congress channels.

In close collaboration with the broader HCP Community, this role will own the US unbranded strategy and contribute meaningfully to VYVGART Hytrulo brand strategy, indication planning, and launch readiness. This is an exciting opportunity to join an innovative, growing team and shape a new market development program from the ground up. We seek a strategic, hands-on commercial leader who thrives in a nimble, fast-paced environment, is passionate about science, and is deeply motivated by delivering value to people living with rare diseases.

• Lead, in collaboration with Global, the development and evolution of the Sjögren's disease state education strategy, campaign, messaging platform, and content ecosystem across personal and non-personal channels
• Own integrated HCP media and omnichannel strategy, including audience prioritization, segmentation, investment decisions, activation plans, and optimization
• Lead national and regional congress strategy and execution, including booth experience, educational programming, media integration, KOL engagement, field coordination, and post-congress pull-through
• Set the strategy for peer-to-peer education, including educational priorities, program design, content development, training, execution, measurement, and ongoing optimization
• Support US launch readiness efforts including the development and execution of the HCP branded VYVGART Hytrulo strategy and tactics
• Build strong partnerships and drive alignment across US and Global Marketing, Marketing Operations, Field Sales, Medical Affairs, Market Access, Business Analytics, Compliance, Legal, Regulatory, and agency partners to deliver a…